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Background
Physical exercise is one of the most efficient
and researched strategies available for
improving human health span. As a
way of sustaining muscle contraction
during exercise, cellular mechanisms drive
resources to support ATP production. The
balance between the oxidized and reduced
forms of NAD is important for sustaining
energy-producing metabolic reactions.
NAD+ is a coenzyme involved in pleiotropic
cellular processes, including the regulation
of various metabolic enzymes but also
chromatin remodelling and DNA repair.
In rodents, NAD+ levels have been shown
to decrease with ageing due to a rise in the
activity of the CD38 NAD glycohydrolase
enzyme driving age-related phenotypes,
such as the decay of mitochondrial function
(Yoshino et al. 2018). Thus, because of its
possible therapeutic applications, NAD+
dietary supplement precursors such as
nicotinamide riboside (NR) gained a
lot of attention (Yoshino et al. 2018).
Although the findings are promising, they
are primarily based on studies performed
in invertebrates and mammalian models,
while a subset of recent studies indicates
that the effects of NAD supplementation in
humans might be much more subtle than
whatwas observed in the preclinical studies.
For example, dietary NR supplementation
failed to alter mitochondrial physiology
in the skeletal muscle of obese individuals
(Dollerup et al. 2020), conflicting with the
positive findings in mice.
Nicotinamide riboside supplementation has
no effect on the mitochondrial physiology
of human muscle
In a recent study published in The Journal
of Physiology, Stocks and colleagues
investigated the effects of 1 g NR per day on
skeletal muscle physiology in eight young
male individuals at rest or during exercise
(Stocks et al. 2021). The authors’ hypothesis
was that prior to acute exercise, NR
treatment would increase NAD pools and,
subsequently, boost post-exercise signalling
responses. Based on previous research
on the effects of NR on the availability of
human skeletal muscle NAD+, a 1-week
supplementationwithNRwas chosen. After
that, participants were subjected to exercise
to exhaustion on a bicycle ergometer. The
participants had their physical endurance
evaluated and skeletal muscle biopsies were
collected to determine the consequences
of NR supplementation on post-exercise
signalling responses, including several
metabolic and mitochondrial parameters.
The authors found no changes between
groups in cardio-respiratory performance
parameters after 1 week of supplementation
with NR compared to the group that
received a cellulose placebo. In addition, the
levels of different metabolites commonly
modified during physical exercise, such as
plasma non-esterified fatty acid, glucose,
glycerol and lactate, were unaffected at rest
or with exercise.
Alterations in mitochondrial physiology
and biogenesis are amongst the remarkable
effects of NR supplementation in pre-
clinical studies. Therefore, the authors
investigated if NR would be able to promote
any mitochondrial physiological alterations
with biopsies of the skeletal muscle. Neither
exercise nor NR had significant effects on
mitochondrial oxygen consumption nor
on the levels of different mitochondrial
proteins. The group also monitored
whether NR treatment for 7 days could
modify the levels of sirtuin (SIRT1 and
SIRT3) in human skeletal muscle, as
these are highly modulated by NAD+
dietary supplements in rodents, as well
as mediators of the beneficial outcomes
of these molecules in the rodent models.
SIRT1 and SIRT3 activity were accessed
by measuring the levels of acetylation of
their targets (p53Lys382 and MnSODK122,
respectively) along with the global levels
of protein acetylation, but none of these
parameters were affected by NR during rest
or exercise.
It is known that physical exercise
induces a series of signalling events
in the skeletal muscle, especially in
nutrient sensing pathways. Individuals
presented a significant increase in the
phosphorylation levels of AMPKThr172
and ACCSer79 after exercise. The same
degree of induction was observed with
individuals treated with NR. There was also
not observed any differential activation by
NR on the mRNA levels of PPARGC1A,
which encodes the transcriptional factor
peroxisome proliferator-activated receptor
γ coactivator 1α, a master regulator of
mitochondrial metabolism. In other words,
different from what is observed in rodent
studies, NR does not seem to mimic or
boost the effects of physical exercise on the
activation of different nutrient signalling
pathways in skeletal muscle.
A possibility to explain the absence
of effects of NR would be that the
chosen dosage was not sufficient to
promote significant alterations in the
metabolism of NAD+ in skeletal muscle.
To test this possibility, the skeletal muscle
NAD-metabolome was evaluated by liquid
chromatography–mass spectrometry.
Surprisingly, there were no significant
differences in the levels of NR or NAD+
between the groups that might explain
why the authors were unable to observe
differences in the activity of SIRT1 and
SIRT3. One possibility is that the regulation
of NAD+ levels and NR recycling is more
severely controlled in humans and that
other concentrations or strategies will be
required to modify these metabolite levels.
Nonetheless, they were able to detect a
rise in nicotinic acid mononucleotide,
Nar, Me2PY and Me4Py levels, strongly
indicating that 1 week of NR treatment
was sufficient to alter the human skeletal
NAD metabolome. In future studies, it will
be interesting to include the measurement
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of NADH levels. Although the total levels
of NAD+ are unchanged, one possibility
is that the NAD+/NADH balance could
be influenced by NR treatment. Finally,
the authors measured the transcriptional
level of some genes of the NAD+ synthesis
and salvage pathway. They were able to
identify that physical exercise increases the
expression of the gene for nicotinamide
N-methyltransferase (NNMT) – a
methyltransferase of nicotinamide – and
that this activation is blunted by treatment
with NR. Further studies with NR in
humans should validate this finding in other
cohorts and investigate the physiological
relevance of the differential modulation
of the expression of NNMT by NR. Inter-
estingly, in rats, the regulation of NNMT
activity during exercise has already been
shown to influence the performance of
animals during anaerobic exercise (Zhou
et al. 2018). Finally, another point to be
considered is that S-adenosyl methionine
is a substrate for the NNMT reaction and
it could also be modulated within NR
treatment.
Final considerations and future questions
In concordance with Stocks et al. (2021), a
contemporary study using the same dosage
of NR for 21 days in aged individuals
at rest also did not reveal alterations in
mitochondrial physiology (Elhassan et al.
2019). Conversely, the NAD+ metabolome
was also found to be augmented in elderly
by NR. However, RNA sequencing
of human skeletal muscle detected
downregulation in genes of glycolytic,
tricarboxylic acid and even mitochondrial
pathways after NR supplementation, but
surprisingly, no key changes in NAD+
metabolism genes were found. It is possible
that subtle transcriptional changes could
be found in the study of Stocks et al.
(2021) by employing high throughput
techniques. Based on these observations,
it will be interesting to understand the
mechanisms of how nicotinamide riboside
can modulate the gene expression signature
of human skeletal muscle cells, at least for
aged tissues, if it is not affecting NAD+ or
mitochondrial physiology. In future studies,
one key point to be considered is whether
NR treatment would benefit young healthy
individuals, since they have normal levels of
NAD+. Knowing exercise partially restores
the health of aged tissues and that NR
might have positive responses in elderly, a
promising next approach for a clinical trial
would be to evaluate the combined effects
of exercise and NR supplementation during
ageing (Custodero et al. 2020).
Finally, this study raises a series of
questions for the field. For instance, why is
NR supplementation not so successful in
altering mitochondrial function in human
skeletal muscle when compared to rodent
studies? Studies with larger and more
diverse cohorts and with longer periods
of treatment are required to enlighten
this issue. A promising venue for future
research would be to explore the impact
of NR on other aspects of physical activity,
such as fat mobilization and mitochondrial
function in other tissues. It is also possible
that species-specific optimal strategies to
increase NAD+ levels with external sources
exist. Future studies could investigate
the role of other NAD+ dietary sources,
such as dihydronicotinamide riboside,
which is successful in boosting NAD+ on
rodents through the action of adenosine
kinase.
Conclusion
Taken together, the study of Stocks and
colleagues showed that 1 week of NR
supplementation has no identifiable effects
on human skeletal muscle during rest
or exercise. Nevertheless, further studies
using other demographic populations and
treatment for longer periods of time are
necessary to establish the real potential of
NR for modifying human physiology.
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